The Oralife Group, Inc., a managed health care company focusing on dental disease management, is contemplating an initial public offering. Oralife intended to use proceeds from the issue to fund: clinical trials of new pharmaceutical products and file New Drug Applications for these products; on-going research and development work; sales and marketing activities, including entering the U.S. and European markets; further development of the company's .....more